Tien Ma
Primary Care · Annandale, VANPI 1962982405
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 293 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 41 manufacturers, the largest accounting for just 17.0% — the pattern of someone who eats at a lot of different presentations. Among primary care clinicians in VA with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 293 payments — averaging $25.34 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$1K
- Gilead$817
- AstraZeneca$781
- Novo Nordisk$579
- Amgen$570
- Pfizer$550
- plus $3K from 35 others
What the payments were for
- Food & beverage$7,425100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$7,425 in reported general payments places this provider in the 95th percentile of 142 primary care providers in Virginia.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| JardianceEmpagliflozin | 27 | $42,345 |
| FarxigaDapagliflozin Propanediol | 23 | $36,318 |
| OzempicSemaglutide | 21 | $33,352 |
| TrulicityDulaglutide | 22 | $31,772 |
| EliquisApixaban | 14 | $25,014 |
| JanuviaSitagliptin Phosphate | 14 | $24,079 |
| Trelegy ElliptaFluticasone/Umeclidin/Vilanter | 22 | $20,998 |
| AbrysvoRsv Vacc, Pref A And Pref B/Pf | 52 | $16,089 |
| VascepaIcosapent Ethyl | 18 | $11,209 |
| Lidocaine | 102 | $10,570 |
| ArexvyRsvpref3 Antigen/As01e/Pf | 27 | $7,930 |
| Diclofenac Sodium | 116 | $5,175 |
| Clobetasol Propionate | 96 | $4,284 |
| SymbicortBudesonide/Formoterol Fumarate | 13 | $2,923 |
| Omega-3 Acid Ethyl Esters | 16 | $2,765 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Boehringer IngelheimJardiance | $82 | $42,34527 claims |
| PfizerEliquis, Abrysvo | $550 | $41,10266 claims |
| AstraZenecaFarxiga, Symbicort | $781 | $39,24136 claims |
| Novo NordiskOzempic | $579 | $33,35221 claims |
| Lilly USA, LLCTrulicity | $297 | $31,77222 claims |
| GSKTrelegy Ellipta, Arexvy | $304 | $28,92849 claims |
| MerckJanuvia | $33 | $24,07914 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 142 primary care providers in Virginia.
Other primary care in Annandale
- Rebecca GrinsellRichmond$12K
- Jennifer CampbellNewport News$8K
- Michael CogginAshland$7K
- Erin StewartFredericksburg$6K
- Lawanda WoodNorfolk$6K
- Sara WeaverDanville$5K
- Luis Rivera PenaFalls Church$4K
- Erika RobinsonFredericksburg$4K
- Haley SwansonVirginia Beach$4K
- Lisa LewisDanville$4K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.